Your account is not claimed yet. You can sign up with ORCID to claim your account.

Rob M Ewing (R M Ewing)

Years Active: 2018-2021
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Emily Bowler-Barnett, Francisco Drusso Martinez-Garcia, Matthew Sherwood, Ahood Aleidan, Steve John, Sara Weston, Yihua Wang, Nullin Divecha, Paul Skipp, Rob M Ewing
Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells. PloS one 16 (11) (2021)
Emily H Bowler, Alex Smith-Vidal, Alex Lester, Joseph Bell, Zhenghe Wang, Christopher G Bell, Yihua Wang, Nullin Divecha, Paul J Skipp, Rob M Ewing
Deep proteomic analysis of Dnmt1 mutant/hypomorphic colorectal cancer cells reveals dysregulation of epithelial-mesenchymal transition and subcellular re-localization of Beta-Catenin. Epigenetics 15 (1-2) (2019)
Emily H Bowler, Joseph Bell, Nullin Divecha, Paul Skipp, Rob M Ewing
Proteomic Analysis of Azacitidine-Induced Degradation Profiles Identifies Multiple Chromatin and Epigenetic Regulators Including Uhrf1 and Dnmt1 as Sensitive to Azacitidine. Journal of proteome research 18 (3) (2019)
Rob M Ewing, Jing Song, Giridharan Gokulrangan, Sheldon Bai, Emily H Bowler, Rachel Bolton, Paul Skipp, Yihua Wang, Zhenghe Wang
Multiproteomic and Transcriptomic Analysis of Oncogenic β-Catenin Molecular Networks. Journal of proteome research 17 (6) (2018)
D Liu, Y Skomorovska, J Song, E Bowler, R Harris, M Ravasz, S Bai, M Ayati, K Tamai, M Koyuturk, X Yuan, Z Wang, Yihua Wang, Rob M Ewing
ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1. Cancer biology & therapy 20 (1) (2018)

Rob M Ewing.css-eqlu8i{font-size:small;padding-left:4px;} (R M Ewing)